Leadership Overview
SPIMACO has 5 executives leading key functions including strategy, manufacturing operations, financial management, and human resources development.
Committed to advancing regional healthcare, SPIMACO drives the development and manufacturing of essential medicinal products while fostering innovation in pharmaceutical research across Saudi Arabia and broader international markets.
Committed to advancing regional healthcare, SPIMACO drives the development and manufacturing of essential medicinal products while fostering innovation in pharmaceutical research across Saudi Arabia and broader international markets.
Leadership Roles at SPIMACO
Hany Alhussainy - Group Chief Executive Officer
Hany Alhussainy, the Group Chief Executive Officer at SPIMACO, directs the overarching corporate strategy and long-term vision for the organization. Overseeing the entire pharmaceutical manufacturing portfolio, the Group Chief Executive Officer ensures alignment between production capabilities and the evolving needs of the regional healthcare sector. This leadership role involves managing complex stakeholder relationships and driving operational excellence across all manufacturing facilities. By prioritizing high-quality medicinal formulations, Hany Alhussainy strengthens the market position of the company within the competitive pharmaceutical landscape. The Group Chief Executive Officer also coordinates with the Board to secure sustainable growth and financial stability. Through rigorous oversight of internal processes, the Group Chief Executive Officer maintains strict adherence to international quality standards. Ultimately, Alhussainy fosters a culture of innovation that supports the mission of delivering reliable medical solutions to patients throughout the Middle East and beyond.
Quaisar Anwar - Api Subsidiary CAD Executive Director & Chief Executive Officer
Quaisar Anwar, the Api Subsidiary CAD Executive Director & Chief Executive Officer at SPIMACO, manages the specialized operations of the active pharmaceutical ingredient division. Overseeing the technical development and manufacturing workflows, the Api Subsidiary CAD Executive Director & Chief Executive Officer ensures the consistent supply of high-grade raw materials for medicinal formulations. This leadership role involves optimizing supply chain logistics and enhancing production efficiency to meet growing market demand. By integrating advanced research methodologies, Quaisar Anwar drives the expansion of the subsidiary capabilities within the broader corporate framework. The Api Subsidiary CAD Executive Director & Chief Executive Officer also collaborates with the executive team to align production targets with the strategic goals of the organization. Through meticulous management of technical resources, the Api Subsidiary CAD Executive Director & Chief Executive Officer secures the integrity of the pharmaceutical supply chain. Ultimately, Anwar supports the company mission by ensuring the availability of critical components for life-saving medications.
Abdulaziz Al-Oud - Chief Financial Officer
Abdulaziz Al-Oud, the Chief Financial Officer at SPIMACO, directs the financial planning, reporting, and capital allocation strategies for the entire organization. Overseeing the fiscal health of the company, the Chief Financial Officer ensures that all investments in pharmaceutical manufacturing and research align with long-term profitability goals. This leadership role involves managing complex financial risks and optimizing the capital structure to support regional expansion efforts. By implementing robust financial controls, Abdulaziz Al-Oud maintains transparency and accountability across all business units. The Chief Financial Officer also provides critical data-driven insights to the Board to facilitate informed decision-making regarding market investments. Through the rigorous analysis of operational costs and revenue streams, the Chief Financial Officer secures the financial foundation necessary for sustained growth. Ultimately, Al-Oud drives the economic performance of the company, ensuring that resources remain effectively deployed to advance the development of essential medical products and pharmaceutical formulations.
Maha Alkhuraisi - Executive Assistant To Chief Human Resources Officer
Maha Alkhuraisi, the Executive Assistant To Chief Human Resources Officer at SPIMACO, coordinates the administrative functions and strategic initiatives within the human resources department. Overseeing the operational flow of talent management programs, the Executive Assistant To Chief Human Resources Officer ensures that recruitment and employee development processes support the broader organizational goals. This leadership role involves facilitating communication between the human resources department and other executive functions to maintain organizational alignment. By streamlining internal workflows, Maha Alkhuraisi enhances the efficiency of workforce planning and performance management systems. The Executive Assistant To Chief Human Resources Officer also manages critical documentation and scheduling for high-level personnel projects. Through the effective organization of departmental resources, the Executive Assistant To Chief Human Resources Officer supports the cultivation of a skilled workforce capable of meeting the demands of the pharmaceutical industry. Ultimately, Alkhuraisi contributes to the operational success of the company by ensuring that human capital initiatives remain focused on excellence.
Maha Alsalem - Executive Assistant To Chief Human Resources Officer
Maha Alsalem, the Executive Assistant To Chief Human Resources Officer at SPIMACO, manages the administrative infrastructure and project coordination for the human resources division. Overseeing the implementation of employee engagement strategies, the Executive Assistant To Chief Human Resources Officer ensures that corporate culture initiatives remain consistent with the mission of the company. This leadership role involves analyzing workforce data to support the development of training programs and retention policies. By coordinating cross-departmental efforts, Maha Alsalem fosters a collaborative environment that drives productivity across the manufacturing and research teams. The Executive Assistant To Chief Human Resources Officer also assists in the execution of organizational change management projects to improve internal processes. Through the diligent management of administrative tasks, the Executive Assistant To Chief Human Resources Officer enables the leadership team to focus on high-level talent acquisition and development. Ultimately, Alsalem supports the growth of the company by ensuring that human resources operations remain agile and responsive to business needs.
Explore Leadership Teams in Manufacturing
Morepen Laboratories is a leading pharmaceutical company specializing in Active Pharmaceutical Ingredients (APIs) and finished formulations. With a commitment to quality and innovation, the company offers a wide range of healthcare, grooming, and OTC products under trusted brands like Dr. Morepen and Gubb World, catering to over 100 million consumers. Morepen has a robust global presence, exporting to over 80 countries and holding certifications from regulatory authorities such as USFDA and WHO GMP. The company is dedicated to enhancing lives through its extensive research and development efforts and state-of-the-art manufacturing facilities.
Company Leadership VS
KS
Founded in 1958 and headquartered in Chatswood, Australia, iNova Pharmaceuticals is an international organization that develops, markets, and sells a wide-range of prescription medicines and non-prescription consumer health products across Asia, Australia and New Zealand, and Africa.
Company Leadership DS
JR
SE

Since 2006, Pharos Indonesia has been the fastest growing pharmaceutical company in Indonesia, achieving 40% annual growth. In 2009, based on IMS* reports, Pharos became the 4th largest Indonesian pharmaceutical company; jumping from position 12 in just 4 years. Pharos marketing teams have forged strong relationships with major hospital groups as well as individual doctors, including specialists and this ensures strong distribution of our products. No other pharmaceutical manufacturer, nor retail pharmacy group, can compete with the strength of the Pharos-controlled network of almost 2,000 pharmacies spread across Indonesia. Pharos is uniquely positioned to take advantage of the large and fast-growing ASEAN region.
Company Leadership VP
RR
AL
HD
Founded in 1990, Divi's Laboratories is a pharmaceutical company that specializes in the manufacturing in custom synthesizes generic APIs, intermediates and nutraceutical ingredients. Divi's Laboratories is located in India.
Company Leadership

KL
MJ